Lyell Immunopharma Inc (LYEL)
0.95
+0.03
(+3.64%)
USD |
NASDAQ |
Nov 22, 16:00
0.9478
0.00 (0.00%)
After-Hours: 20:00
Lyell Immunopharma Shareholders Equity (Quarterly): 530.70M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 530.70M |
| June 30, 2024 | 566.50M |
| March 31, 2024 | 603.16M |
| December 31, 2023 | 654.95M |
| September 30, 2023 | 697.57M |
| June 30, 2023 | 736.86M |
| March 31, 2023 | 783.83M |
| December 31, 2022 | 833.25M |
| Date | Value |
|---|---|
| September 30, 2022 | 820.03M |
| June 30, 2022 | 868.04M |
| March 31, 2022 | 881.25M |
| December 31, 2021 | 929.79M |
| September 30, 2021 | 986.47M |
| June 30, 2021 | 1.022B |
| March 31, 2021 | 676.92M |
| December 31, 2020 | 718.44M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
530.70M
Minimum
Sep 2024
1.022B
Maximum
Jun 2021
769.36M
Average
760.34M
Median
Shareholders Equity (Quarterly) Benchmarks
| Chimerix Inc | 135.78M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
| Theriva Biologics Inc | 24.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 619.22M |
| Total Liabilities (Quarterly) | 88.52M |
| Current Ratio | 13.43 |